INNV
Get informed when a big investor buys or sells
+ FollowOvervalued by 123.7% based on the discounted cash flow analysis.
| Market cap | $1.46 Billion |
|---|---|
| Enterprise Value | $1.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 0.39 |
| Outstanding Shares | 135,812,522 |
| P/E Ratio | -519.32 |
|---|---|
| PEG | 44.94 |
| Price to Sales | 1.54 |
| Price to Book Ratio | 10.75 |
| Enterprise Value to Revenue | 1.49 |
| Enterprise Value to EBIT | 32.16 |
| Enterprise Value to Net Income | -67 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.37 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 28,200▲ 127.42% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 13.72%▲ 1.92% |
|---|---|
| Total Invested | $219.75M▲ 71.71% |
| Investors Holding | 110▲ 7.00% |
No data
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Its mission is to enable seniors to age independently in their own homes for as long as possible. Its patient-centered care model meaningfully improves...